Need Help?
Contact Us

IT TAKES COLLABORATION TO MAKE SCIENCE MORE MEANINGFUL

  • News Releases

    Boston Scientific to Participate in 27th Annual Credit Suisse Healthcare Conference

    MARLBOROUGH, Mass., Nov. 6, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, Arizona.

    Joe Fitzgerald, executive vice president and president, rhythm management, Mark Bickel, vice president, controller, rhythm management, and Susie Lisa, vice president, investor relations, will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 9:10 a.m. MST / 11:10 a.m. EST.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

    A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

    About Boston Scientific
    Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

    CONTACTS


    Media:                                        

    Investors:

    Kate Haranis                                  

    Susie Lisa, CFA

    508-683-6585 (office)                       

    508- 683-5565 (office)

    Media Relations                                  

    Investor Relations

    Boston Scientific Corporation               

    Boston Scientific Corporation

    Kate.Haranis@bsci.com                         

    BSXInvestorRelations@bsci.com

     

     

    SOURCE Boston Scientific Corporation